Recommendation: ACCUMULATE · Rating 6.9/10
Our current reading of TJKB11 is ACCUMULATE, with a score of 6.9/10. This score comes neither from the manager nor the administrator: it is Rico aos Poucos' editorial assessment, built from the documents the fund files with the CVM. Below is what supports it — and what argues against it.
Leads the bucket (1st/3). It is the only non-single-asset fund in the group: ~40 hospital and clinical properties, 100% of leases atypical (WAULT 11+ years) indexed to IPCA, and the highest dividend yield (~13.7%). While NSLU11 and HCRI11 depend on a single property/tenant (Rede D'Or), TJKB11 dilutes counterparty risk across dozens of assets while still delivering real net asset growth. It does not warrant a BUY rating because it has accumulated two cash-flow focuses (4 properties on installment plans through Oct/2026 + Neolink postponement), the capital gains that supported part of the DPU dried up in Q2/2026, and liquidity is extremely low (~R$ 77k/day). ACCUMULATE.
Safety in a REIT is not yes or no — it is how much risk you accept. TJKB11 has a medio risk profile. What that means in practice:
| Component | Level |
|---|---|
| Concentração | 2.5 |
| Price volatility | 2.5 |
| Distribution volatility | 2.0 |
| Liquidez | 4.5 |
| Underlying asset risk | 3.5 |
| Financial/leverage risk | 2.0 |
ECOVIS auditors issued an EMPHASIS OF MATTER paragraph in the 2025 Audit Report indicating that certain property deeds do not yet reflect the transfer of ownership to the Fund's assets. By value: Ed. Mykonos (R$ 9.98M), Neolink (R$ 21.2M), and Barra Private (R$ 33.0M) total R$ 64M (10.5% of net assets).
Procedures underway; explanatory note 7 clarifies the status; an operational risk, not an ownership risk.
Each property is dedicated to 1 tenant (BTS/sale-and-leaseback) with specialized installations (surgery, oncology, ophthalmology). Anchor tenant departure requires significant retrofitting to re-lease—the secondary market for hospital real estate is narrow. An 11.45-year WAULT mitigates, but does not eliminate, the risk.
Atypical leases carry substantial termination penalties; tenants are well-capitalized (AFYA, Oncoclínicas).
4 properties (Marselhesa, Tatuapé, Av. Brasil, and Borba Gato) experienced payment delays in Mar/26, structured into 3 installments. These 4 properties account for ~13.5% of net assets. Simultaneous delinquency across 4 leases suggests a common issue (same tenant group? same sector under stress?). The material fact notice refers to 'tenant' in the singular—indicating potential hidden concentration.
Negotiation concluded with a payment plan; the manager did not signal risk of total default. Monitor the next 3 management reports.
CRI 43 (Series 1: R$ 10M at CDI + 4.35% + Series 2: R$ 10M at IPCA + 9.00%) begins principal repayment in Oct/2026, spread over 48 and 88 installments, respectively. Additional cash outflows, even if small, pressure DPU if revenue from the Instituto do Sono fails to convert as projected.
The administrator may opt for early amortization depending on strategy.
Units jumped from 1.16M to ~2.13M with the integration of the Instituto do Sono. The installment-based capital gain (R$ 13M over 12 months) is now diluted across significantly more units. If the real yield on the new properties falls below 10.52% p.a., DPU will decline structurally.
A 15-year atypical lease at R$ 2.38M/month indexed to IPCA covers debt service and generates a margin if actual revenue hits projections.
Rental revenue from the Neolink properties was not received for the May/16-Jun/15 period. This adds a second set of cash flow problems beyond the 4 already delinquent properties. If Neolink also fails to regularize by Jul/26, the R$ 2.90 DPU will come under pressure even with installment-based capital gains offsetting it.
The manager stated this is a one-off deferral, not a delinquency. Adjustments were applied in June, signaling that the lease remains active.
| Scenario | Description |
|---|---|
| Full conversion of the Instituto do Sono in Oct/2026 | Stabilized collection from the 3 new Vila Mariana properties (R$ 2.38M/month, IPCA+) lifts DPU to R$ 3.00-3.15 and closes the discount to book value |
| Declining Selic rates open a window for discounted FIIs | Focus survey projects Selic at 11% (May/2027). Long atypical FIIs typically reprice by +10-15% during easing cycles—TJKB11 could rise to R$ 280-290 |
| Normalization of delinquency in Jun/2026 | Completion of the 3 regularization installments for the 4 delinquent properties confirms it was a one-off event—restoring confidence in a stable R$ 2.90 DPU |
| Delinquency deepens—tenant in the traditional SP block departs | Marselhesa + Tatuapé + Av. Brasil + Borba Gato account for ~13% of net assets. If the delinquent tenant(s) enter total default, the impact on DPU is -R$ 0.40-0.50/unit until re-leasing (12-24 months) |
| Negative fair-value adjustment in the 2026 Binswanger appraisal report | The Nov/2025 appraisal brought a +R$ 40M positive gain. In a rising cap rate cycle (high Selic + healthcare sector delinquency), the 2026 appraisal could reverse part of this gain, dropping book value per unit from R$ 283 to R$ 265-275—making the apparent P/BV less attractive |
| ANS/CRM health-regulator rules in São Paulo impact key operator | 55% of GLA is in São Paulo. Local regulatory changes (consultation pricing, accreditation requirements, oversight) affecting hospital operators (Oncoclínicas, AFYA, Instituto do Sono) could pressure rent-paying capacity |
TJKB11 is a pure healthcare FII with a differentiated value proposition in the Brazilian market: 40 hospital and clinical assets in SP+SC+RJ, 100% long atypical leases (WAULT of 11.45 years), 95% inflation-linked, with 100% occupancy sustained for 4+ years. For investors seeking rare sector exposure (healthcare has only ~5 pure FIIs in the market), TJKB11 delivers on paper quality.
However, actual execution exposed two weaknesses in 2026: (1) delinquency in 4 properties in Mar/2026 (~13% of net assets) forced a DPU cut to R$ 2.50, with a regularization plan set in 3 installments through Jun/26; (2) cash flow mismatch between the 4th offering (3 Instituto do Sono properties acquired in Mar/26) and the start of revenue collection (Apr/26) precipitated the cut that same month. In Apr/26, the DPU returned to R$ 2.90.
The P/BV of 0.90 is not as extreme a discount as it appears at first glance. Book value was inflated by a R$ 40M fair value adjustment in the Binswanger appraisal in Nov/2025, and the auditor flagged in an emphasis of matter that title deeds for R$ 64M in properties (Mykonos, Neolink, Barra Private) have not yet been transferred to the fund. The 13.70% dividend yield is the highest in the hospital subsegment, but it reflects a risk premium for current delinquency and installment capital gains that run out in Dec/26.
Low liquidity (R$ 77k/day in May/26 with only 648 unitholders) is the primary constraint: TJKB11 does not fit portfolios with more than R$ 500k to allocate. For a satellite position (3–5% of an FII portfolio), it offers genuine sector diversification and inflation protection. For a retiree's core portfolio, the history of 3 DPU cuts in 4 years (Jun/23, Apr/25, Mar/26) is incompatible with the objective.
Current recommendation: ACCUMULATE. Rating 6.9/10. TJKB11 is one of the few Brazilian REIT-style funds (FIIs) in Brazil with an exclusive mandate in healthcare — encompassing roughly 40 hospital and clinical properties spread across São Paulo, Joinville, and Rio de Janeiro, all with long-term leases (average term of 11 years)…
Our current read on TJKB11 is “ACCUMULATE”. Rating 6.9/10. Assess it against your risk profile and the points of attention listed above.
The main points of attention for TJK Renda Imobiliária FII include: Delinquency of the 4 properties normalized — but cycle only ends in Oct/2026; Capital gains from the Oct/2024 sale have ended — DPU now relies solely on operations with double the unit count; Low liquidity (~R$ 77k/day, May/26); Geographic concentration in São Paulo (55% of GLA).
TJKB11 is suitable for: Investors seeking rare sector exposure to healthcare (not found in hybrid FIIs) Moderate-to-aggressive profile with a 5-10 year horizon Investors willing to accept low liquidity in exchange for an 11.45-year WAULT with IPCA protection